TF Capital, a venture capital firm in China, invests in high-potential, early-stage life sciences companies.
Location
Shanghai, CN
Founded
2015
TF Capital is a venture capital firm focused on early-stage investments in the life sciences industry. Based in China, the firm targets high-potential companies, typically participating in Series A and Series B funding rounds. Their investment strategy centers on identifying promising opportunities in the biotechnology and pharmaceutical sectors.
Notable portfolio companies include Allorion Therapeutics, AskGene Pharma, Regor Therapeutics, Sanegene Bio, and Zai Lab. These investments demonstrate TF Capital's commitment to supporting innovative life sciences companies with significant growth potential. The firm has contributed to substantial funding rounds, with several portfolio companies raising $80 million or more in total capital.
TF Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
